JR11-PEG3-DOTA-PSMA-03
JR11-PEG3-DOTA-PSMA-03 (Compound 2) is an RDC-related compound containing the chelating agent DOTA (HY-W053583), the JR11 peptide (SSTR2 antagonist), and the PSMA ligand. JR11-PEG3-DOTA-PSMA-03 shows SSTR2-binding affinities and PSMA-binding affinities, with IC50 s of 94.0 nM, 81.8 nM, respectively. JR11-PEG3-DOTA-PSMA-03 can be radiolabeled with [68Ga]. [68Ga] radiolabeled JR11-PEG3-DOTA-PSMA-03 can be used in diagnostic studies of neuroendocrine differentiated prostate cancer.
For research use only. We do not sell to patients.
- Formula: C123H165ClN26O41S2
- Molecular Weight:2763.36
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
All Radionuclide-Drug Conjugates (RDCs) Isoforms
More
Biological Activity
|
SSTR2 |
Chemical Information
-
Molecular Weight 2763.36
-
Formula C123H165ClN26O41S2
-
Sequence
{Phe(p-Cl)}-cyclo({d-Cys}-Phe-{d-4-amino-Phe(carbamoyl)}-Lys-Thr-Cys){d-Tyr}-NH2-PEG3-DOTA-PSMA-03
-
Sequence Shortening
{Phe(p-Cl)}-cyclo({d-Cys}-F-{d-4-amino-Phe(carbamoyl)}-KTC){d-Tyr}-NH2-PEG3-DOTA-PSMA-03
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
JR11-PEG3-DOTA-PSMA-03 Related Classifications
HY-P11488 Related Classifications
Powered by Bioz